SEARCH RESULTS FOR: (*purchase New Brunswick driver*)(184493 results)
Only the first 10,000 results were returned. Filter these results or refine your query. Some pre-built queries with more than 10,000 results are available for download.
Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%
hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP).
Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process.
Wiltrom Co., Ltd. (Chutung)
BC-G03(0.5-1.0mm,5c.c.)
In Commercial Distribution
- 04719873029884 ()
- Synthetic bone graft
Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%
hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP).
Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process.
Wiltrom Co., Ltd. (Chutung)
BC-G02(1.0-2.0mm,5c.c.)
In Commercial Distribution
- 04719873029877 ()
- Synthetic bone graft
Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%
hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP).
Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process.
Wiltrom Co., Ltd. (Chutung)
BC-G01(2.0-3.0mm,5c.c.)
In Commercial Distribution
- 04719873027729 ()
- Synthetic bone graft
Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%
hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP).
Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process.
Wiltrom Co., Ltd. (Chutung)
BC-B12 (5x5x10mm,30c.c.)
In Commercial Distribution
- 04719873027712 ()
- Synthetic bone graft
Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%
hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP).
Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process.
Wiltrom Co., Ltd. (Chutung)
BC-B11 (5x5x10mm,20c.c.)
In Commercial Distribution
- 04719873027705 ()
- Synthetic bone graft
Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%
hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP).
Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process.
Wiltrom Co., Ltd. (Chutung)
BC-B10 (5x5x20mm,30c.c.)
In Commercial Distribution
- 04719873027699 ()
- Synthetic bone graft
Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%
hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP).
Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process.
Wiltrom Co., Ltd. (Chutung)
BC-B09 (5x5x20mm,20c.c.)
In Commercial Distribution
- 04719873027682 ()
- Synthetic bone graft
Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%
hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP).
Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process.
Wiltrom Co., Ltd. (Chutung)
BC-B08 (5x5x20mm,10c.c.)
In Commercial Distribution
- 04719873027675 ()
- Synthetic bone graft
Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%
hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP).
Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process.
Wiltrom Co., Ltd. (Chutung)
BC-B07(5x5x20mm,7c.c.)
In Commercial Distribution
- 04719873027668 ()
- Synthetic bone graft
Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%
hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP).
Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process.
Wiltrom Co., Ltd. (Chutung)
BC-B06(5x5x20mm,5c.c.)
In Commercial Distribution
- 04719873027651 ()
- Synthetic bone graft